Clinical trials
Terminated Phase 4 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
162 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 6 |
| 2004 | 11 |
| 2005 | 6 |
| 2006 | 11 |
| 2007 | 13 |
| 2008 | 18 |
| 2009 | 13 |
| 2010 | 10 |
| 2011 | 15 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 8 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 162 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 11 |
| Pfizer | 8 |
| DePuy International | 6 |
| Hannover Medical School | 5 |
| Hoffmann-La Roche | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 4 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 |
| University Hospital Muenster | 4 |
| B. Braun Melsungen AG | 3 |
| Biogen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 9 |
| Arthritis, Rheumatoid | 6 |
| Atrial Fibrillation | 6 |
| Coronary Artery Disease | 6 |
| Osteoarthritis | 6 |
| Heart Failure | 5 |
| Breast Neoplasms | 4 |
| Epilepsy | 4 |
| Hip Dislocation, Congenital | 4 |
| Multiple Sclerosis, Relapsing-Remitting | 4 |
Trials
Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.
62 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.